Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yolanda M Gómez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Reumatologia Clinica|October 5, 2025
Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in ChileMarcos Cruces Olivar, Allan D Burboa, Yolanda M Gómez
Statistics in Medicine|September 28, 2021
On a new piecewise regression model with cure rate: Diagnostics and application to medical dataYolanda M Gómez, Diego I Gallardo, Jeremias Leão, et al.
Statistical Methods in Medical Research|September 28, 2019
On the use of the modified power series family of distributions in a cure rate model contextDiego I Gallardo, Yolanda M Gómez, Héctor W Gómez, et al.
Scientific Reports|August 17, 2025
The multivariate shared truncated normal frailty model with application to medical dataDiego I Gallardo, Yolanda M Gómez, John L Santibañez, et al.
Lifetime Data Analysis|September 16, 2022
A general class of promotion time cure rate models with a new biological interpretationYolanda M Gómez, Diego I Gallardo, Marcelo Bourguignon, et al.
Scientific Reports|July 2, 2025
A new proportional hazard model with applications to breastfeeding dataYolanda M Gómez, Wilson E Caimanque, John L Santibáñez, et al.
Frontiers in Immunology|August 12, 2024
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patientsMaria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M Gómez, et al.
Bioorganic & Medicinal Chemistry|March 25, 2020
Anti-inflammatory effect and inhibition of nitric oxide production by targeting COXs and iNOS enzymes with the 1,2-diphenylbenzimidazole pharmacophoreMónica I García-Aranda, Jazmin E Gonzalez-Padilla, Carlos Z Gómez-Castro, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Reumatologia Clinica|October 5, 2025
Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in ChileMarcos Cruces Olivar, Allan D Burboa, Yolanda M Gómez
Statistics in Medicine|September 28, 2021
On a new piecewise regression model with cure rate: Diagnostics and application to medical dataYolanda M Gómez, Diego I Gallardo, Jeremias Leão, et al.
Statistical Methods in Medical Research|September 28, 2019
On the use of the modified power series family of distributions in a cure rate model contextDiego I Gallardo, Yolanda M Gómez, Héctor W Gómez, et al.
Scientific Reports|August 17, 2025
The multivariate shared truncated normal frailty model with application to medical dataDiego I Gallardo, Yolanda M Gómez, John L Santibañez, et al.
Lifetime Data Analysis|September 16, 2022
A general class of promotion time cure rate models with a new biological interpretationYolanda M Gómez, Diego I Gallardo, Marcelo Bourguignon, et al.
Scientific Reports|July 2, 2025
A new proportional hazard model with applications to breastfeeding dataYolanda M Gómez, Wilson E Caimanque, John L Santibáñez, et al.
Frontiers in Immunology|August 12, 2024
4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patientsMaria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M Gómez, et al.
Bioorganic & Medicinal Chemistry|March 25, 2020
Anti-inflammatory effect and inhibition of nitric oxide production by targeting COXs and iNOS enzymes with the 1,2-diphenylbenzimidazole pharmacophoreMónica I García-Aranda, Jazmin E Gonzalez-Padilla, Carlos Z Gómez-Castro, et al.
Pageof 1